Skip to main content
. 2016 Dec 20;129(24):2899–2906. doi: 10.4103/0366-6999.195461

Figure 3.

Figure 3

Mean change from baseline in Qmax (a) and postvoid residual volume (b) of the four treatment groups. *P < 0.05 versus placebo; P < 0.05 versus tamsulosin; P < 0.05 versus tolterodine extended release (ER); §P < 0.05 versus tolterodine ER + tamsulosin.